Lee SH - Search Results

1

Inflamed immune phenotype predicts favorable clinical outcomes of immune checkpoint inhibitor therapy across multiple cancer types.

Shen J, Choi YL, Lee T, Kim H, Chae YK, Dulken BW, Bogdan S, Huang M, Fisher GA, Park S, Lee SH, Hwang JE, Chung JH, Kim L, Song H, Pereira S, Shin S, Lim Y, Ahn CH, Kim S, Oum C, Kim S, Park G, Song S, Jung W, Kim S, Bang YJ, Mok TSK, Ali SM, Ock CY. Shen J, et al. Among authors: lee sh, lee t. J Immunother Cancer. 2024 Feb 14;12(2):e008339. doi: 10.1136/jitc-2023-008339. J Immunother Cancer. 2024. PMID: 38355279 Free PMC article.

2

A phase III randomized trial of combined chemoradiotherapy versus radiotherapy alone in locally advanced non-small-cell lung cancer.

Kim TY, Yang SH, Lee SH, Park YS, Im YH, Kang WK, Ha SH, Park CI, Heo DS, Bang YJ, Kim NK. Kim TY, et al. Among authors: lee sh. Am J Clin Oncol. 2002 Jun;25(3):238-43. doi: 10.1097/00000421-200206000-00007. Am J Clin Oncol. 2002. PMID: 12040280 Clinical Trial.

3

Efficacy of modified regimen with attenuated doses of paclitaxel plus carboplatin combination chemotherapy in elderly and/or weak patients with advanced non-small cell lung cancer.

Choi IS, Kim BS, Park SR, Lee SY, Kim DY, Kim JH, Lee SH, Kim TY, Heo DS, Bang YJ, Kim NK. Choi IS, et al. Among authors: lee sh, lee sy. Lung Cancer. 2003 Jan;39(1):99-101. doi: 10.1016/s0169-5002(02)00389-6. Lung Cancer. 2003. PMID: 12499101 Clinical Trial.

4

Phase II study of chemotherapy with ACNU plus cisplatin followed by cranial irradiation in patients with newly diagnosed glioblastoma multiforme.

Choi IS, Lee SH, Kim TY, Bang JS, Paek SH, Kim S, Kim IH, Heo DS, Bang YJ, Kim DG, Jung HW, Kim NK. Choi IS, et al. Among authors: lee sh. J Neurooncol. 2002 Nov;60(2):171-6. doi: 10.1023/a:1020605617452. J Neurooncol. 2002. PMID: 12635665 Clinical Trial.

5

Impact of multimodality approach for patients with leptomeningeal metastases from solid tumors.

Kwon J, Chie EK, Kim K, Kim HJ, Wu HG, Kim IH, Oh DY, Lee SH, Kim DW, Im SA, Kim TY, Heo DS, Bang YJ, Ha SW. Kwon J, et al. Among authors: lee sh. J Korean Med Sci. 2014 Aug;29(8):1094-101. doi: 10.3346/jkms.2014.29.8.1094. Epub 2014 Jul 30. J Korean Med Sci. 2014. PMID: 25120319 Free PMC article.

6

Intratumoral heterogeneity characterized by pretreatment PET in non-small cell lung cancer patients predicts progression-free survival on EGFR tyrosine kinase inhibitor.

Park S, Ha S, Lee SH, Paeng JC, Keam B, Kim TM, Kim DW, Heo DS. Park S, et al. Among authors: lee sh. PLoS One. 2018 Jan 31;13(1):e0189766. doi: 10.1371/journal.pone.0189766. eCollection 2018. PLoS One. 2018. PMID: 29385152 Free PMC article.

7

EGFR Mutation Is Associated with Short Progression-Free Survival in Patients with Stage III Non-squamous Cell Lung Cancer Treated with Concurrent Chemoradiotherapy.

Park SE, Noh JM, Kim YJ, Lee HS, Cho JH, Lim SW, Ahn YC, Pyo H, Choi YL, Han J, Sun JM, Lee SH, Ahn JS, Park K, Ahn MJ. Park SE, et al. Among authors: lee sh, lee hs. Cancer Res Treat. 2019 Apr;51(2):493-501. doi: 10.4143/crt.2018.125. Epub 2018 Jun 18. Cancer Res Treat. 2019. PMID: 29914238 Free PMC article. Clinical Trial.

8

Improved treatment outcome of pembrolizumab in patients with nonsmall cell lung cancer and chronic obstructive pulmonary disease.

Shin SH, Park HY, Im Y, Jung HA, Sun JM, Ahn JS, Ahn MJ, Park K, Lee HY, Lee SH. Shin SH, et al. Among authors: lee sh, lee hy. Int J Cancer. 2019 Nov 1;145(9):2433-2439. doi: 10.1002/ijc.32235. Epub 2019 Mar 25. Int J Cancer. 2019. PMID: 30807641

9

Genomic landscape of acquired resistance to third-generation EGFR tyrosine kinase inhibitors in EGFR T790M-mutant non-small cell lung cancer.

Lee J, Kim HS, Lee B, Kim HK, Sun JM, Ahn JS, Ahn MJ, Park K, Lee SH. Lee J, et al. Among authors: lee sh, lee b. Cancer. 2020 Jun 1;126(11):2704-2712. doi: 10.1002/cncr.32809. Epub 2020 Mar 10. Cancer. 2020. PMID: 32154925 Free article.

10

Artificial Intelligence-Powered Spatial Analysis of Tumor-Infiltrating Lymphocytes as Complementary Biomarker for Immune Checkpoint Inhibition in Non-Small-Cell Lung Cancer.

Park S, Ock CY, Kim H, Pereira S, Park S, Ma M, Choi S, Kim S, Shin S, Aum BJ, Paeng K, Yoo D, Cha H, Park S, Suh KJ, Jung HA, Kim SH, Kim YJ, Sun JM, Chung JH, Ahn JS, Ahn MJ, Lee JS, Park K, Song SY, Bang YJ, Choi YL, Mok TS, Lee SH. Park S, et al. Among authors: lee sh, lee js. J Clin Oncol. 2022 Jun 10;40(17):1916-1928. doi: 10.1200/JCO.21.02010. Epub 2022 Mar 10. J Clin Oncol. 2022. PMID: 35271299 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

24,379 results

Search Page

Filters